Relafen 750, the advanced formulation of naproxen, offers a fascinating study from our biochemical pharmacy perspective. This mechanism of action, primarily involving inhibition of cyclooxygenase enzymes and COX-1 and COX-2 – results to significant decrease in prostaglandin creation. Considering